Sponsor
The Parkinson Study Group
Clinical research sponsor
Clinical trials
19 shownSafety of Urate Elevation in Parkinson's DiseaseNCT00833690 · lead sponsor · 2009-06-01
COMPLETEDDiagnostic and Prognostic Biomarkers in Parkinson DiseaseNCT00653783 · lead sponsor · 2007-08-01
UNKNOWNA Longitudinal Observational Follow-up of the PRECEPT Study CohortNCT00605163 · lead sponsor · 2006-08-01
UNKNOWNPOETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's DiseaseNCT00234676 · lead sponsor · 2003-10-01
COMPLETEDAn Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)NCT06996652 · collaborator · 2026-08-17
RECRUITINGLow-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's DiseaseNCT07005180 · collaborator · 2026-06-30
RECRUITINGParkinson's Foundation PD GENEration Genetic RegistryNCT04994015 · collaborator · 2020-12-20
RECRUITINGStudy in Parkinson Disease of ExerciseNCT04284436 · collaborator · 2021-08-30
ACTIVE_NOT_RECRUITINGAuricular Muscle Zone Stimulation for Parkinson DiseaseNCT04652583 · collaborator · 2021-05-01
COMPLETEDA 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's DiseaseNCT04658186 · collaborator · 2020-12-30
COMPLETEDPDGeneration: Mapping the Future of Parkinson's DiseaseNCT04057794 · collaborator · 2019-08-15
UNKNOWNAssessing Tele-Health Outcomes in Multiyear Extensions of PD TrialsNCT03538262 · collaborator · 2018-10-01
COMPLETEDValidation of a Non-Motor Fluctuation Assessment Instrument (NoMoFA) for Parkinson's DiseaseNCT03845634 · collaborator · 2018-09-13
COMPLETEDStudy of Urate Elevation in Parkinson's Disease, Phase 3NCT02642393 · collaborator · 2016-06-01
COMPLETEDEfficacy of Isradipine in Early Parkinson DiseaseNCT02168842 · collaborator · 2014-11-01
COMPLETEDNicotine Treatment of Impulsivity in Parkinson's DiseaseNCT01216904 · collaborator · 2010-10-01
UNKNOWNSafety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson DiseaseNCT00909545 · collaborator · 2009-07-01
COMPLETEDSafety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's DiseaseNCT00040404 · collaborator · 2002-03-01
TERMINATEDParkinson's Research: The Organized Genetics InitiativeNCT00086073 · collaborator · 1998-08-01
COMPLETEDSponsor roles
collaborator15
lead sponsor4
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.